Eli Lilly and Novo Nordisk Strike Weight-Loss Drug Deal with Trump Administration
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co. ...
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co. ...
Tuesday’s trading session saw major pharmaceutical deals, biotech setbacks, and a surprise comeback in the car rental sector. On Tuesday’s ...
Disappointing Data Spurs $125 Billion Market Value Drop Novo Nordisk’s (NVO) ambitions in the competitive obesity drug market took a ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?